- Home
- ASGN vs BHVN Comparison
ASGN vs BHVN Comparison
Compare ASGN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- BHVN
- Stock Information
- Founded
- ASGN 1985
- BHVN 2013
- Country
- ASGN United States
- BHVN United States
- Employees
- ASGN N/A
- BHVN N/A
- Industry
- ASGN Professional Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- ASGN Consumer Discretionary
- BHVN Health Care
- Exchange
- ASGN Nasdaq
- BHVN Nasdaq
- Market Cap
- ASGN 4.2B
- BHVN 3.6B
- IPO Year
- ASGN 1992
- BHVN 2017
- Fundamental
- Price
- ASGN $88.43
- BHVN $37.58
- Analyst Decision
- ASGN Buy
- BHVN Strong Buy
- Analyst Count
- ASGN 4
- BHVN 13
- Target Price
- ASGN $101.75
- BHVN $63.00
- AVG Volume (30 Days)
- ASGN 313.2K
- BHVN 1.2M
- Earning Date
- ASGN 02-05-2025
- BHVN 02-27-2025
- Dividend Yield
- ASGN N/A
- BHVN N/A
- EPS Growth
- ASGN N/A
- BHVN N/A
- EPS
- ASGN 3.96
- BHVN N/A
- Revenue
- ASGN $4,188,800,000.00
- BHVN N/A
- Revenue This Year
- ASGN N/A
- BHVN N/A
- Revenue Next Year
- ASGN $1.86
- BHVN $197.13
- P/E Ratio
- ASGN $22.34
- BHVN N/A
- Revenue Growth
- ASGN N/A
- BHVN N/A
- 52 Week Low
- ASGN $82.04
- BHVN $26.80
- 52 Week High
- ASGN $106.42
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- ASGN 55.27
- BHVN 45.91
- Support Level
- ASGN $84.87
- BHVN $35.01
- Resistance Level
- ASGN $87.02
- BHVN $40.46
- Average True Range (ATR)
- ASGN 1.97
- BHVN 2.12
- MACD
- ASGN 0.72
- BHVN 0.27
- Stochastic Oscillator
- ASGN 75.73
- BHVN 54.02
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.